| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 38.84 | 21.7% | 56.4% |
| Total Income | 38.84 | 21.7% | 56.4% |
| Expenditure | 128.85 | 11.9% | 10.7% |
| PBT | -80.75 | 33.3% | 42.2% |
| Net Profit | -80.76 | 33.9% | 43.2% |
| OPM | — | ||
| NPM | — | ||
| EPS | -1.45 | 31.8% | 34.3% |
Ginkgo Bioworks Reports Q3 2025 Revenue of $39 Million
04 May 2026 · 4 May, 7:48 am
Summary
Ginkgo Bioworks announced its third quarter 2025 financial results, with total revenue of $39 million compared to $89 million in the prior year. Excluding a non-cash revenue release from the previous year, revenue decreased by 11%. The company reported a GAAP net loss of $(81) million and an adjusted EBITDA of $(56) million. Ginkgo reaffirmed its full year 2025 total revenue outlook of $167-$187 million.
Key Highlights
- 1
Ginkgo Bioworks reported total revenue of $39 million for the third quarter of 2025, compared to $89 million in the prior year period.
- 2
Excluding a $45 million non-cash revenue release in the prior year, total revenue decreased by 11% year-over-year in the third quarter of 2025.
- 3
Cell Engineering revenue for the third quarter of 2025 was $29 million, a decrease of 61% compared to $75 million in the prior year period.
- 4
Biosecurity revenue for the third quarter of 2025 amounted to $9 million, compared to $14 million in the prior year period.
- 5
GAAP net loss for the third quarter of 2025 was $(81) million, compared to $(56) million in the prior year period.
- 6
Adjusted EBITDA for the third quarter of 2025 was $(56) million, down from $(20) million in the prior year period.
- 7
Ginkgo reaffirms total revenue of $167-$187 million in 2025.
Management Comments
Jason Kelly
Our recent partnership announcements are powerful examples of how Ginkgo’s AI-enabled cloud lab technology can be deployed to accelerate U.S. scientific innovation. The recent AI Action Plan from President Trump specifically called for investment in AI-enabled cloud laboratories to keep the American bioeconomy competitive. Ginkgo’s tools are designed to generate the massive, high-quality datasets that modern AI methods need, furthering the goal of the U.S. remaining at the forefront of the bioeconomy.
Informational and educational content only. Not investment advice.